Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents

Severe complications related to COVID-19 occur infrequently in children and adolescents. these life-threatening complications are mainly acute respiratory failure from acute COVID-19 and multisystem inflammatory syndrome in children (MIS-C). MIS-C is a postinfectious complication occurring approxima...

Descripción completa

Detalles Bibliográficos
Autores principales: Blatz, Allison M., Randolph, Adrienne G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743385/
https://www.ncbi.nlm.nih.gov/pubmed/35667744
http://dx.doi.org/10.1016/j.ccc.2022.01.005
_version_ 1784629891748069376
author Blatz, Allison M.
Randolph, Adrienne G.
author_facet Blatz, Allison M.
Randolph, Adrienne G.
author_sort Blatz, Allison M.
collection PubMed
description Severe complications related to COVID-19 occur infrequently in children and adolescents. these life-threatening complications are mainly acute respiratory failure from acute COVID-19 and multisystem inflammatory syndrome in children (MIS-C). MIS-C is a postinfectious complication occurring approximately 3 to 6 weeks mostly after an asymptomatic or mild SARS-CoV-2 infection. For both types of complications, supportive ICU care is often required. For MIS-C critical illness, immunomodulation is prescribed to reverse hyperinflammation and its cardiac and other sequelae.
format Online
Article
Text
id pubmed-8743385
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-87433852022-01-10 Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents Blatz, Allison M. Randolph, Adrienne G. Crit Care Clin Article Severe complications related to COVID-19 occur infrequently in children and adolescents. these life-threatening complications are mainly acute respiratory failure from acute COVID-19 and multisystem inflammatory syndrome in children (MIS-C). MIS-C is a postinfectious complication occurring approximately 3 to 6 weeks mostly after an asymptomatic or mild SARS-CoV-2 infection. For both types of complications, supportive ICU care is often required. For MIS-C critical illness, immunomodulation is prescribed to reverse hyperinflammation and its cardiac and other sequelae. Elsevier Inc. 2022-07 2022-01-10 /pmc/articles/PMC8743385/ /pubmed/35667744 http://dx.doi.org/10.1016/j.ccc.2022.01.005 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Blatz, Allison M.
Randolph, Adrienne G.
Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
title Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
title_full Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
title_fullStr Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
title_full_unstemmed Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
title_short Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
title_sort severe covid-19 and multisystem inflammatory syndrome in children in children and adolescents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743385/
https://www.ncbi.nlm.nih.gov/pubmed/35667744
http://dx.doi.org/10.1016/j.ccc.2022.01.005
work_keys_str_mv AT blatzallisonm severecovid19andmultisysteminflammatorysyndromeinchildreninchildrenandadolescents
AT randolphadrienneg severecovid19andmultisysteminflammatorysyndromeinchildreninchildrenandadolescents

Ejemplares similares